Expert studies have found that people who previously suffered from Covid-19 could be living with a “silent killer.”
Researchers say they have found a reaction to the virus which has no symptoms but which can be slowly damaging a vital part of the brain. They have claimed there is a chance some people may be more at risk of brain disorders such as Parkinson's and Alzheimer's as a result.
However, they say although it is showing up as a potential future risk for those who have had the virus, it could also offer a possible treatment. The team was led by The University of Queensland and carried out tests on the brain's immune cells - "microglia".
Read more: Pharmacy bandit nabbed in Coolock after week of robberies
The study discovered the virus activates the same inflammatory response in the brain as Parkinson’s disease. The team was led by Professor Trent Woodruff and Dr. Eduardo Albornoz Balmaceda from UQ’s School of Biomedical Sciences, and virologists from the School of Chemistry and Molecular Biosciences.
Prof Woodruff said: “Our team grew human microglia in the laboratory and infected the cells with SARS-CoV-2, the virus that causes Covid-19. We found the cells effectively became ‘angry’, activating the same pathway that Parkinson’s and Alzheimer’s proteins can activate in disease, the inflammasomes.”
Dr. Albornoz Balmaceda said triggering the inflammasome pathway sparked a ‘fire’ in the brain. This then kicked off a chronic and sustained process of killing off neurons - which are known as the 'information messengers' of the brain which send messages around the brain and the nervous system.
He said: “It’s kind of a silent killer because you don’t see any outward symptoms for many years. It may explain why some people who’ve had Covid-19 are more vulnerable to developing neurological symptoms similar to Parkinson’s disease.” The researchers say they found the spike protein of the virus was enough to start the process. It was further exacerbated when there were already proteins in the brain linked to Parkinson’s.
Prof Woodruff said: “So if someone is already pre-disposed to Parkinson’s, having Covid-19 could be like pouring more fuel on that ‘fire’ in the brain. The same would apply for a predisposition for Alzheimer’s and other dementias that have been linked to inflammasomes.”
But the study also claims to have found a potential treatment. The researchers administered a class of UQ-developed inhibitory drugs that are currently in clinical trials with Parkinson’s patients.
“We found it successfully blocked the inflammatory pathway activated by Covid-19, essentially putting out the fire,” Dr. Albornoz Balmaceda said. “The drug reduced inflammation in both Covid-19-infected mice and the microglia cells from humans, suggesting a possible treatment approach to prevent neurodegeneration in the future.”
Professor Woodruff said while the similarity between how Covid-19 and dementia diseases affect the brain was concerning, it also meant a possible treatment was already in existence.
He said: “Further research is needed, but this is potentially a new approach to treating a virus that could otherwise have untold long-term health ramifications.”
READ NEXT:
Family of tragic Tallaght twins gather on their birthday weeks after killings
Paschal Donohoe to be nominated for Eurogroup presidency despite Fianna Fáil unease
- Ronan Keating's ‘heart is broken’ as he says goodbye to daughter Missy before move to Australia
- 107-year-old Boyzone super fan receives special birthday message from Ronan Keating
Dublin dad 'ecstatic' to have baby triplets home in Ireland after debacle in Kenya
Sign up to the Dublin Live Newsletter to get all the latest Dublin news straight to your inbox.
